Disopyramide

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2155 publications

Medical management of hypertrophic cardiomyopathy.

Medical management of hypertrophic cardiomyopathy.

Journal: Indian heart journal

Published: May 05, 2026

Use of Disopyramide in Obstructive Hypertrophic Cardiomyopathy: A European Insight.

Use of Disopyramide in Obstructive Hypertrophic Cardiomyopathy: A European Insight.

Journal: Journal of clinical medicine

Published: April 29, 2026

Microglial PICALM: A novel genetic driver and therapeutic target in vascular dementia.

Microglial PICALM: A novel genetic driver and therapeutic target in vascular dementia.

Journal: Archives of gerontology and geriatrics

Published: April 03, 2026

Recommendations from the Clinical Toxicology Recommendations Collaborative on the administration of activated charcoal in acute oral overdose.

Recommendations from the Clinical Toxicology Recommendations Collaborative on the administration of activated charcoal in acute oral overdose.

Journal: Clinical toxicology (Philadelphia, Pa.)

Published: March 30, 2026

Pharmacologic therapies for hypertrophic cardiomyopathy: The past, the present, and the future.

Pharmacologic therapies for hypertrophic cardiomyopathy: The past, the present, and the future.

Journal: JRSM cardiovascular disease

Published: February 19, 2026

CYP450 activity, drug interactions, and genetic polymorphisms: clinical relevance for the new selective cardiac myosin inhibitors.

CYP450 activity, drug interactions, and genetic polymorphisms: clinical relevance for the new selective cardiac myosin inhibitors.

Journal: Expert opinion on drug safety

Published: November 28, 2025

Therapeutic Sequencing in Obstructive Hypertrophic Cardiomyopathy: Seeing the Forest Through the Trees.

Therapeutic Sequencing in Obstructive Hypertrophic Cardiomyopathy: Seeing the Forest Through the Trees.

Journal: JACC. Heart failure

Published: November 14, 2025

One- and two-year structural changes of mavacamten therapy in hypertrophic obstructive cardiomyopathy: a case report with serial comprehensive CMR demonstrating continuous reverse remodelling.

One- and two-year structural changes of mavacamten therapy in hypertrophic obstructive cardiomyopathy: a case report with serial comprehensive CMR demonstrating continuous reverse remodelling.

Journal: European heart journal. Case reports

Published: October 16, 2025

Targeting the Sarcomere: Myosin Inhibitors as the Revolutionary Game Changer in Hypertrophic Cardiomyopathy.

Targeting the Sarcomere: Myosin Inhibitors as the Revolutionary Game Changer in Hypertrophic Cardiomyopathy.

Journal: Reviews in cardiovascular medicine

Published: October 14, 2025

Frequently Underappreciated Considerations in Anti-arrhythmic Drug Therapy.

Frequently Underappreciated Considerations in Anti-arrhythmic Drug Therapy.

Journal: The Journal of innovations in cardiac rhythm management

Published: August 28, 2025

EJHF expert consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.

EJHF expert consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.

Journal: European journal of heart failure

Published: July 22, 2025

Mavacamten in Symptomatic Patients Resistant to Previous Advanced Therapy for Obstructive Hypertrophic Cardiomyopathy.

Mavacamten in Symptomatic Patients Resistant to Previous Advanced Therapy for Obstructive Hypertrophic Cardiomyopathy.

Journal: Journal of the American Heart Association

Published: July 17, 2025

Showing 1-12 of 2,155

Last Updated: 06/30/2026